You are required to be logged in to access the full website
Click here if you have forgotten your username or password
1 June 2026 - Chinese biopharmaceutical company Dizal (SSE:688192) announced on Saturday the presentation of two studies in non-small cell lung cancer (NSCLC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.One study evaluated...
1 June 2026 - TiumBio Co Ltd (KOSDAQ:321550), a South Korea-based clinical-stage biopharmaceutical company, on Sunday announced clinical data for Tosposertib (TU2218), an oral dual inhibitor targeting transforming growth factor-beta (TGF-beta) and va...
1 June 2026 - Chinese biopharmaceutical company ImmVira Group announced on Sunday that preliminary Phase IIa clinical data for MVR-T3011, its lead oncolytic immunotherapy candidate, was presented at the 2026 American Society of Clinical Oncology (ASC...
1 June 2026 - CARsgen Therapeutics Holdings Limited (HK:2171), a Chinese developer of innovative CAR T-cell therapies, announced on Monday that the long-term analysis results of satricabtagene autoleucel (satri-cel, CT041) (an autologous CAR T-cell p...
1 June 2026 - South Korea-based pharmaceutical company Hanmi Pharm. Co. Ltd. announced on Monday that it has entered into a licence agreement for the development, manufacturing and commercialisation of its biologic drug candidate sonefpeglutide (LAPS...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe